Sierra Oncology Inc (SRRA) Stock Analyst Earnings Estimates
NASDAQ:SRRA - Nasdaq - US82640U4040 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 300K | -100.00% | 29.269M | 173.586M 493.07% | 425.456M 145.10% | 1.064B 150.00% | ||||
| EBITDA YoY % growth | -55.31M -30.57% | -66.91M -20.97% | -64.7M 3.30% | N/A -45.72% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -55.42M -30.03% | -66.99M -20.88% | -64.94M 3.06% | -93.539M -45.64% | -100.978M -6.76% | -89.993M 10.88% | 2.825M 103.14% | 1.278M -54.77% | 589.465K -53.87% | |
| Operating Margin | N/A | N/A | -21,646.67% | N/A | N/A | -307.47% | 1.63% | 0.30% | 0.06% | |
| EPS YoY % growth | -30.00 11.76% | -29.48 1.73% | -5.91 79.95% | -7.22 -20.98% | -4.89 31.62% | -3.94 19.37% | 0.02 100.60% | 0.01 -60.18% | 0.00 -59.38% |
| Q2 / 22 | Q3 / 22 | Q4 / 22 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.97 41.98% | -1.12 46.81% | -1.30 22.13% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -21.447M -4.26% | -25.045M 12.43% | -28.494M -11.35% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | -1.33 22.22% | -1.05 | -0.28 | -27.00% |
| Q4 2021 Q2Q % growth | -1.67 -2.45% | -1.57 | -0.10 | -6.45% |
| Q3 2021 Q2Q % growth | -2.10 -51.08% | -1.82 | -0.28 | -15.70% |
| Q2 2021 Q2Q % growth | -1.67 -5.70% | -1.65 | -0.02 | -1.38% |
| Q1 2021 Q2Q % growth | -1.71 -30.53% | -1.64 | -0.07 | -4.45% |
| Q4 2020 Q2Q % growth | -1.63 79.31% | -1.55 | -0.08 | -5.31% |
| Q3 2020 Q2Q % growth | -1.39 79.56% | -1.68 | 0.29 | 17.03% |
| Q2 2020 Q2Q % growth | -1.58 80.25% | -1.66 | 0.08 | 4.75% |
| Q1 2020 Q2Q % growth | -1.31 80.74% | -2.79 | 1.48 | 53.13% |
| Q4 2019 Q2Q % growth | -7.88 | -3.23 | -4.65 | -144.09% |
| Q3 2019 Q2Q % growth | -6.80 | -8.57 | 1.77 | 20.63% |
| Q2 2019 Q2Q % growth | -8.00 | -8.02 | 0.02 | 0.30% |
| Q1 2019 Q2Q % growth | -6.80 | -8.43 | 1.63 | 19.36% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |